US Stock MarketDetailed Quotes

BCYC Bicycle Therapeutics

Watchlist
  • 8.305
  • -0.115-1.37%
Trading Apr 28 14:33 ET
575.15MMarket Cap-2.86P/E (TTM)

About Bicycle Therapeutics Company

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.

Company Profile

SymbolBCYC
Company NameBicycle Therapeutics
Listing DateMay 23, 2019
Issue Price14.00
Founded2009
CEODr. Kevin Lee, M.B.A.,PhD
MarketNASDAQ
Employees305
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressGranta Park Great Abington,Portway Building,Blocks A & B
CityCambridge
ProvinceCambridgeshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeCB21 6GS
Phone44-1223-261503
Websitehttp://bicycletherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Kevin Lee, M.B.A.,PhD
  • Director and Chief Executive Officer
  • 4.86M
  • Travis Thompson
  • Chief Accounting Officer
  • --
  • Dr. Eric Westin, M.D.
  • Chief Medical Officer
  • --
  • Alethia Young
  • Chief Financial Officer
  • 1.47M
  • Alistair Milnes
  • Chief Operating Officer
  • 2.59M
  • Dr. Michael Skynner, PhD
  • Chief Technology Officer
  • --
  • Dr. Michael Charles Ferguson Hannay, D.Sc.
  • Chief Product and Supply Chain Officer
  • 2.37M
  • Jim MacDonald-Clink
  • Senior Vice President and Head of Business Development
  • --
  • Pierre Legault, C.P.A.,M.B.A.
  • Chairman of the Board
  • 906.61K
  • Dr. Fabrice Andre, M.D.,PhD
  • Director
  • --
  • Richard N. Kender, M.B.A.
  • Independent Director
  • 374.60K
  • Dr. Felix J. Baker,PhD
  • Independent Director
  • 658.32K
  • Dr. Alessandro Riva, M.D.
  • Independent Director
  • --
  • Sir Greg Winter, F.R.S.
  • Independent Director
  • 327.72K
  • Janice Bourque, M.B.A.
  • Independent Director
  • 343.44K
  • Stephen Sands
  • Independent Director
  • 711.92K
  • Dr. Jose-Carlos Gutierrez-Ramos, PhD
  • Independent Director
  • 342.18K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
3.065
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
8.690
New Fortress Energy
NFE
5.735
4
Hutchmed (China)
HCM
15.000
5
Lantheus
LNTH
102.565
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.